Development of new weight loss drug supported by Novo Nordisk
Significant investment in the development of a new oral weight loss drug
New oral PCSK-9 inhibitor demonstrates efficacy and safety
The first orally administered PCSK-9 inhibitor is safe and effective.
Contact
Moje srdce s.r.o.
E-mail: podpora@mojesrdce.cz
Tel. +420 735 922 853
Oblouková 848/25
Prague 10, 10100
